SciCombinator

Discover the most talked about and latest scientific content & concepts.

Long-term Efficacy of Vedolizumab for Ulcerative Colitis

Journal of Crohn's & colitis | 30 Sep 2016

EV Loftus, JF Colombel, BG Feagan, S Vermeire, WJ Sandborn, BE Sands, S Danese, GR D'Haens, A Kaser, R Panaccione, DT Rubin, I Shafran, M McAuliffe, A Kaviya, S Sankoh, R Mody, B Abhyankar and M Smyth
Abstract
The GEMINI long-term safety (LTS) study is a continuing phase 3 trial investigating the safety and efficacy of vedolizumab, an α4β7 integrin antagonist for ulcerative colitis (UC) and Crohn’s disease. We provide an interim analysis of efficacy in patients with UC.
Tweets*
8
Facebook likes*
0
Reddit*
0
News coverage*
72
Blogs*
0
SC clicks
0
Concepts
Diarrhea, Colonoscopy, Abdominal pain, Infliximab, Colitis, Colon, Crohn's disease, Ulcerative colitis
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com